Which has the lower trailing P/E, HRMY or UFPT?

HRMY has the lower trailing P/E: HRMY trades at 12.78 and UFPT at 32.67. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, HRMY or UFPT?

Over the past five years, HRMY grew revenue faster — HRMY at a 32.47% CAGR versus UFPT at 27.47%.

Is HRMY or UFPT more profitable?

HRMY runs the higher net margin — HRMY at 18.88% versus UFPT at 11.45%.

How have HRMY and UFPT total returns compared?

Over the past 5 years, HRMY delivered 0.91% and UFPT delivered 37.11% annualized total return. Past performance doesn't predict future results.

Harmony Biosciences Holdings, Inc. (HRMY) vs UFP Technologies, Inc. (UFPT)

A side-by-side comparison of Harmony Biosciences Holdings, Inc. and UFP Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

HRMY

Harmony Biosciences Holdings, Inc.

$2.28B

$39.36HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

UFPT

UFP Technologies, Inc.

$2.34B

$302.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — HRMY vs UFPT

growth of $100 · dividends reinvested · last 6y

HRMY +7.9% (+1.3%/yr)UFPT +600.5% (+38.3%/yr)UFPT compounded faster over this window

Log scale — wide-divergence pair

HRMY UFPT

HRMY vs UFPT: by the numbers

•UFPT is the larger company ($2.34B vs $2.28B market cap).
•HRMY trades at the lower trailing earnings multiple (12.78 vs 32.67 P/E), one valuation lens rather than an overall verdict.
•HRMY converts more revenue to profit (18.88% vs 11.45% net margin).
•HRMY grew revenue faster over the past five years (32.47% vs 27.47% CAGR).

Metrics side by side

Valuation

Metric	HRMY	UFPT
P/E ratio	12.78	32.67
Forward P/E	9.98	31.09
PEG ratio	N/A	0.87
P/S ratio	2.37	3.71
P/B ratio	2.28	5.07
EV / EBITDA	7.36	20.54
FCF yield	15.57%	2.62%

Profitability

Metric	HRMY	UFPT
Gross margin	75.42%	28.50%
Operating margin	24.03%	15.25%
Net margin	18.88%	11.45%
ROE	18.14%	15.63%
ROIC	14.96%	12.75%

Growth (annualized)

Metric	HRMY	UFPT
Revenue CAGR (5Y)	32.47%	27.47%
EPS CAGR (5Y)	N/A	37.73%
FCF CAGR (5Y)	48.43%	26.87%
Total return CAGR (5Y)	0.91%	37.11%

Frequently asked

Which has the lower trailing P/E, HRMY or UFPT?: HRMY has the lower trailing P/E: HRMY trades at 12.78 and UFPT at 32.67. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, HRMY or UFPT?: Over the past five years, HRMY grew revenue faster — HRMY at a 32.47% CAGR versus UFPT at 27.47%.
Is HRMY or UFPT more profitable?: HRMY runs the higher net margin — HRMY at 18.88% versus UFPT at 11.45%.
How have HRMY and UFPT total returns compared?: Over the past 5 years, HRMY delivered 0.91% and UFPT delivered 37.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full HRMY analysis Full UFPT analysis Interactive comparison tool

Dig into the metrics

Harmony Biosciences P/E ratio UFP Technologies P/E ratio Harmony Biosciences ROE UFP Technologies ROE Harmony Biosciences operating margin UFP Technologies operating margin Harmony Biosciences revenue growth UFP Technologies revenue growth Harmony Biosciences free cash flow UFP Technologies free cash flow

Harmony Biosciences & UFP Technologies appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.